BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9443744)

  • 1. The role of the gallium scan in primary extranodal lymphoma.
    Hussain R; Christie DR; Gebski V; Barton MB; Gruenewald SM
    J Nucl Med; 1998 Jan; 39(1):95-8. PubMed ID: 9443744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
    Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
    J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.
    Gallamini A; Biggi A; Fruttero A; Pugno F; Cavallero G; Pregno P; Grasso M; Farinelli C; Leone A; Gallo E
    Eur J Nucl Med; 1997 Dec; 24(12):1499-506. PubMed ID: 9391185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three cases demonstrating the role of gallium scanning in relapsing Hodgkin's disease and non-Hodgkin lymphoma.
    Zollars LE; Nagel JS; Tumeh SS
    J Nucl Med; 1987 Oct; 28(10):1611-5. PubMed ID: 3655913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
    Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
    J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary non-Hodgkin's malignant lymphoma of the breast: long-term follow-up.
    Imai T; Shiga T
    Breast; 2004 Apr; 13(2):152-4. PubMed ID: 15019698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pretreatment risk factors and Ga-67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non-Hodgkin lymphoma.
    Israel O; Mor M; Epelbaum R; Frenkel A; Haim N; Dann EJ; Gaitini D; Bar-Shalom R; Kolodny GM; Front D
    Cancer; 2002 Feb; 94(4):873-8. PubMed ID: 11920453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of gallium-67 citrate scintigraphy in gastro-intestinal malignant lymphoma].
    Kataoka M; Tsuda T; Kawamura M; Itoh H; Komatsu A; Mogami H; Tanada S; Iio A; Hamamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):155-63. PubMed ID: 2362795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [False-positive findings of 67-gallium scintigraphy in staging/restaging of malignant lymphoma].
    Bihl H; Kimmig B
    Rofo; 1987 Feb; 146(2):172-7. PubMed ID: 3029830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium scanning in the diagnosis and management of orbital lymphoma: a case report.
    Warwar RE; Bullock JD
    Ophthalmic Plast Reconstr Surg; 1999 May; 15(3):180-4. PubMed ID: 10355836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallium-67-citrate scintigraphy of high-grade T-cell non-Hodgkin's lymphoma.
    Lipp RW; Sill H; Aigner R; Ranner G; Hoefler G; Passath A; Leb G
    J Nucl Med; 1996 Sep; 37(9):1524-5. PubMed ID: 8790208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
    Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
    Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed positive thallium uptake in large B-cell non-Hodgkin's malignant lymphoma.
    Abdel-Dayem HM; Naddaf SY; Omar WS; Aziz M; Gillooley J
    J Nucl Med; 1997 Aug; 38(8):1213-5. PubMed ID: 9255153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scintigraphy with radiogallium in oncologic and non-oncologic diseases. State of the art and main indications].
    Gasparini M; Tondini C; Musumeci R; Spinelli F; Monetti N; Bombardieri E; Piffanelli A
    Radiol Med; 1996 Dec; 92(6):770-7. PubMed ID: 9122470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual mediastinal mass in malignant lymphoma: value of magnetic resonance imaging and gallium scan.
    Brice P; Rain JD; Frija J; Miaux Y; Marolleau JP; Tredaniel J; Ferme C; Hennequin C; Gisselbrecht C
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):457-61. PubMed ID: 8414967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of 67Ga scintigraphy in extranodal malignant lymphoma patients.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Nagai M; Ohkawa M
    Ann Nucl Med; 2003 Dec; 17(8):657-62. PubMed ID: 14971607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallium-67-citrate scanning for the localization and staging of lymphomas.
    Adler S; Parthasarathy KL; Bakshi SP; Stutzman L
    J Nucl Med; 1975 Apr; 16(4):255-60. PubMed ID: 1089769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive gallium-67 citrate scintigraphy in Wiskott-Aldrich syndrome with malignant lymphoma.
    Sandrock D; Lastoria S; Merino MJ; Neumann RD
    Eur J Nucl Med; 1991; 18(11):928-30. PubMed ID: 1752263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.